Compagnie Lombard Odier SCmA’s NovoCure NVCR Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1K	Hold	930	–	–	﹤0.01%	417
2026 Q1	$10.1K	Sell	930 -3,000	-76%	-$37.5K	﹤0.01%	388
2025 Q4	$50.8K	Hold	3,930	–	–	﹤0.01%	335
2025 Q3	$50.8K	Hold	3,930	–	–	﹤0.01%	342
2025 Q2	$70K	Hold	3,930	–	–	﹤0.01%	309
2025 Q1	$70K	Hold	3,930	–	–	﹤0.01%	334
2024 Q4	$117K	Hold	3,930	–	–	﹤0.01%	283
2024 Q3	$61.4K	Hold	3,930	–	–	﹤0.01%	327
2024 Q2	$67.3K	Hold	3,930	–	–	﹤0.01%	314
2024 Q1	$61.4K	Hold	3,930	–	–	﹤0.01%	341
2023 Q4	$58.7K	Hold	3,930	–	–	﹤0.01%	394
2023 Q3	$63.5K	Hold	3,930	–	–	﹤0.01%	400
2023 Q2	$163K	Hold	3,930	–	–	﹤0.01%	300
2023 Q1	$236K	Buy	3,930 +850	+28%	+$67.9K	0.01%	264
2022 Q4	$226K	Hold	3,080	–	–	0.01%	276
2022 Q3	$234K	Hold	3,080	–	–	0.01%	280
2022 Q2	$214K	Hold	3,080	–	–	0.01%	285
2022 Q1	$255K	Hold	3,080	–	–	0.01%	281
2021 Q4	$231K	Buy	3,080 +40	+1%	+$4.01K	﹤0.01%	338
2021 Q3	$354K	Hold	3,040	–	–	0.01%	287
2021 Q2	$674K	Hold	3,040	–	–	0.01%	198
2021 Q1	$402K	Buy	3,040 +40	+1%	+$6.33K	0.01%	309
2020 Q4	$519K	Hold	3,000	–	–	0.01%	219
2020 Q3	$334K	Hold	3,000	–	–	0.01%	227
2020 Q2	$178K	Hold	3,000	–	–	0.01%	276
2020 Q1	$202K	Hold	3,000	–	–	0.01%	241
2019 Q4	$253K	Hold	3,000	–	–	0.01%	235
2019 Q3	$224K	Buy	+3,000	New	+$240K	0.01%	237

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Compagnie Lombard Odier SCmA's NVCR Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA held its NovoCure (NVCR) position steady in Q2 2026 at 930 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #417.

Compagnie Lombard Odier SCmA first reported a position in NVCR in Q3 2019 and has held it in 28 quarters since. The position peaked at $674K in Q2 2021. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Compagnie Lombard Odier SCmA held 930 shares of NovoCure worth $14.1K as of Q2 2026.
Compagnie Lombard Odier SCmA left its NovoCure share count unchanged in Q2 2026.
NovoCure made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #417 holding.
Compagnie Lombard Odier SCmA first reported a position in NovoCure in Q3 2019 and has held it in 28 quarters since.
Compagnie Lombard Odier SCmA's NovoCure position peaked at $674K in Q2 2021.
218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.